Artwork for podcast The LDN Radio Show About Low Dose Naltrexone
Jenn's Story of Managing MCAS, EDS and POTS
Episode 626th February 2025 • The LDN Radio Show About Low Dose Naltrexone • Linda Elsegood
00:00:00 00:24:05

Share Episode

Shownotes

Jenn from Canada shared her experience with mast cell activation syndrome (MCAS) and Ehlers-Danlos syndrome (EDS). She described experiencing symptoms of disautonomia and dislocations from a young age. Her health challenges worsened during her teen years with symptoms such as mold exposure, recurrent hospitalizations for mystery illnesses, and autoimmune-related issues. It wasn't until two years ago that she was diagnosed with MCAS after discovering hidden mold in her home. After consulting with an allergist and starting on a personalized treatment cocktail, including low-dose naltrexone (LDN), she noticed improvements in her chronic headaches, sleep, and other symptoms. The LDN helped alleviate her symptoms more than she expected and significantly improved her quality of life.

Links

Chapters

Video

More from YouTube